The Scott & White Neuroscience Institute, housed at Baylor Scott & White Medical Center – Temple, was created to treat patients with neurological disorders and conditions. With a commitment to patient care, education and research, our multidisciplinary team of physicians have built a nationally acclaimed healthcare organization.
The Neuroscience Institute is a fully integrated model, with medical professionals and specialists trained to treat the spectrum of neurological care. The teams are complemented by highly skilled support staff and advanced technology to treat a wide range of neurological conditions, including:
- Alzheimer’s disease
- Brain injuries, such as a concussion
- Cerebrovascular disease, which can lead to a stroke
- Parkinson's disease
- Spinal disease
- Movement disorders
- Chronic headache
- Brain and spine tumors
The Neuroscience Institute offers the complete spectrum of diagnostics and treatment. With specialists from neurology, neurosurgery, neuro-oncology, neuropsychology and neurointerventional surgery, we offer advanced and individualized treatment plans for patients
Comprehensive Stroke Center
The stroke program at Baylor Scott and White Medical Center – Temple has been a Joint Commission certified stroke center since 2010. This distinction is given to centers that demonstrate their stroke care program follows national standards and guidelines that can significantly improve outcomes for stroke patients.
Baylor Scott & White Medical Center – Temple's Primary Stroke Center achievements include:
- 2015, Target Stroke Honor Roll award. To qualify for this award, thrombolytic therapy or clot busting medication FDA approved to treat acute ischemic stroke has to be delivered within 60 minutes of the patient’s arrival to the emergency department at least 50 percent of the time
- 2016, American Heart Association/American Stroke Association Get With the Guidelines Gold Plus
- 2016, Target Stroke Honor Roll Elite Plus. To achieve this award clot busting medication must delivered within 60 minutes or less in at least 75 percent of acute ischemic stroke patients AND within 45 minutes or less in at least 50 percent of patients
- For 2017, the median door to needle time to thrombolytic therapy administration was 47 minutes with 87.5 percent of patients received thrombolytic therapy within 60 minutes of emergency department arrival and 54.2 percent of patients received thrombolytic therapy in 45 minutes or less
- Baylor Scott & White Medical Center – Temple had 97.9 percent compliance with all American Heart Association/America Stroke Association Stroke Measures in 2017
- Baylor Scott & White Medical Center – Temple is the 2017 recipient of Target Stroke Honor Roll Elite Plus Award (American Heart Association/America Stroke Association) for quickly delivering clot busting medication. Quickly delivering this clot busting medication has the potential to improve patient outcomes for those who may suffer a stroke.
- 74 patients were treated with clot busting medication
- Less than 1 percent of patients that have a carotid endarterectomy or carotid stenting procedure at Baylor Scott & White Medical Center – Temple have a serious complications (stroke, death, or heart attack) after the procedure which is below the national average. Some patients who have had a stroke or have stroke symptoms may have a blocked artery in the neck area or the artery could be narrowed which can cause a stroke or stroke symptoms because it decreases blood flow to the brain. In order to minimize the stroke risk a provider may recommend the patient has a
carotid endarterectomy or carotid stenting procedure to restore blood flow in the neck artery and to the brain.
Learn how you can identify the signs and symptoms of a stroke.
Brain and Spine Tumor Program
The Scott & White Neuroscience Institute offers expert care for patients battling tumors of the brain and spine. In collaboration with the Scott & White Cancer Institute, the Brain and Spine Tumor Program provides advanced treatment for patients with brain tumors and neurologic complications of cancer.
- Radiation oncologists
- Surgical oncologists
Most brain and spine tumor patients will be seen in the Scott & White Vasicek Cancer Treatment Center on the Temple campus. There, they meet with a team of physicians to determine the best treatment options.
Plummer Movement Disorders Center
The Scott & White Plummer Movement Disorders Center (PMDC) is part of the division of Scott & White's Neurology Department within the Neuroscience Institute. The center offers a variety of treatments for patients suffering from movement disorders.
The full extent of a movement disorder may not be completely understood at first, but may be revealed with comprehensive medical evaluation and diagnostic testing.
Movement disorders also depend on a number of diagnostic tools, including:
- Patient’s complete health history
- Thorough neurological exam by a specialist
- Complete family history
- Magnetic resonance imaging (MRI)
- DAT scans (measure dopamine uptake in the brain)
Scott & White offers a number of treatment options to provide relief from movement disorders, including:
Medication – to help control symptoms and manage depression or anxiety that may accompany the disorder
Botox injections — to relieve muscle contractions and spasms
Lifestyle changes — exercise, diet or stress management
Supportive therapies — physical therapy, occupational therapy and speech therapy
Surgery — depending on the extent of the symptoms
Deep brain stimulation — a surgical procedure used to treat certain neurologic conditions. In this type of treatment, an electrode is implanted surgically into the deep brain structures that influence movement. The conditions most commonly treated with DBS are Parkinson’s disease, dystonia and tremors